XETRA:UN01 News 2 January 2026

January 31, 2026, 2:00 AM EST. Otsuka Holdings (TSE:4578) shares rose 4.1% in the last month and 10.4% over three months, continuing a multi-year upward trend. The stock trades at ¥9,241, above the widely referenced fair value estimate of ¥8,000, indicating possible overvaluation. Analyst bearish price targets go as low as ¥7,200, reflecting concerns about future earnings growth and risks. The company's price-to-earnings (P/E) ratio stands at 10.9x, below the industry average of 16.2x and peer group 25.3x, while a fair P/E could be 23.6x, suggesting room for valuation adjustment. Optimism around Otsuka's pipeline drug sibeprenlimab and profit forecasts could support higher valuations. Investors should weigh these factors carefully amid mixed signals on whether current prices fully reflect growth prospects.